Increased efficacy of μ-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: Comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959)

Psychopharmacology

Volumn 198, Issue 2, 2008, Pages 271-278

  Fischer, Bradford D ^a   Miller, Laurence L ^a   Henry, Fredrick E ^a   Picker, Mitchell J ^a   Dykstra, Linda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Antinociception; Efficacy; Glutamate; Metabotropic; NMDA; Opioid

Indexed keywords

(3,4 DIHYDRO 2H PYRANO[2,3 B]QUINOLIN 7 YL)(4 METHOXYCYCLOHEXYL)METHANONE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; BUPRENORPHINE; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DEZOCINE; JNJ 16259685; METABOTROPIC RECEPTOR ANTAGONIST; MORPHINE SULFATE; MU OPIATE RECEPTOR AGONIST; QUINOLINE DERIVATIVE; AMINO ACID RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; FUSED HETEROCYCLIC RINGS; ISOQUINOLINE DERIVATIVE; METABOTROPIC RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; HOT PLATE TEST; MALE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE; THERMAL STIMULATION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; HEAT; PAIN ASSESSMENT;

ANALGESICS, OPIOID; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BUPRENORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HEAT; ISOQUINOLINES; MALE; MICE; MICE, INBRED C57BL; MORPHINE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, OPIOID, MU; TETRAHYDRONAPHTHALENES;

EID: 43049084429     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1130-y     Document Type: Article

References (28)

1. Allen RM, Dykstra LA (2001) N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys. J Pharmacol Exp Ther 298:288-297
2. Alvarez FJ, Villalba RM, Carr PA, Grandes P, Somohano PM (2000) Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol 422:464-487
3. Bond A, Lodge D (1995) Pharmacology of metabotropic glutamate receptor-mediated enhancement of responses to excitatory and inhibitory amino acids on rat spinal neurones in vivo. Neuropharmacology 34:1015-1023
4. Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, Bouhassira D (2002) Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 98:47-57
5. Cao CQ, Evans RH, Headley PM, Udvarhelyi PM (1995) A comparison of the effects of selective metabotropic glutamate receptor agonists on synaptically evoked whole cell currents of rat spinal ventral horn neurones in vitro. Br J Pharmacol 115:1469-1474
6. Carlton SM, Hargett GL, Coggeshall RE (2001) Localization of metabotropic glutamate receptors 2/3 on primary afferent axons in the rat. Neuroscience 105:957-969
7. Cerne R, Randic M (1992) Modulation of AMPA and NMDA responses in rat spinal dorsal horn neurons by trans-1-aminocyclopentane-1,3-dicarboxylic acid. Neurosci Lett 144:180-184
8. Chen SL, Huang EY, Chow LH, Tao PL (2005) Dextromethorphan differentially affects opioid antinociception in rats. Br J Pharmacol 144:400-404
9. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245-252
10. Fischer BD, Dykstra LA (2006) Interactions between an NMDA antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 318:1300-1306
11. Fischer BD, Zimmerman EI, Picker MJ, Dykstra LA (2008) Morphine in combination with metabotropic glutamate receptor antagonists on schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 324:732-739
12. Gharagozlou P, Demirci H, David Clark J, Lameh J (2003) Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacol 3:1
13. Hoskins PJ, Hanks GW (1991) Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs 41:326-344
14. Jia H, Rustioni A, Valtschanoff JG (1999) Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 410:627-642
15. Jones CK, Eberle EL, Peters SC, Monn JA, Shannon HE (2005) Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing. Neuropharmacology 49:206-218
16. Kelso SR, Nelson TE, Leonard JP (1992) Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol 449:705-718
17. King AE, Liu XH (1996) Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro. Neuropharmacology 35:1673-1680
18. Kozela E, Pilc A, Popik P (2003) Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology 165:245-251
19. Morgan D, Cook CD, Smith MA, Picker MJ (1999) An examination of the interactions between the antinociceptive effects of morphine and various μ-opioids: the role of intrinsic efficacy and stimulus intensity. Anesth Analg 88:407-413
20. Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, Valtschanoff J, Weinberg RJ, Worley PF, Sheng M (1999) Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23:569-582
21. Nemmani KV, Grisel JE, Stowe JR, Smith-Carliss R, Mogil JS (2004) Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109:274-283
22. Preston KL, Jasinski DR (1991) Abuse liability studies of opioid agonist-antagonists in humans. Drug Alcohol Depend 28:49-82
23. Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, Zukin RS (2001) mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40:856-865
24. Toll L (1995) Intact cell binding and the relation to opioid activities in SH-SY5Y cells. J Pharmacol Exp Ther 273:721-727
25. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A, Aakalu VK, Lanahan AA, Sheng M, Worley PF (1999) Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23:583-592
26. Walker EA, Butelman ER, DeCosta BR, Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267:280-286
27. Wessinger WD (1986) Approaches to the study of drug interactions in behavioral pharmacology. Neurosci Biobehav Rev 10:103-113
28. Yoon MH, Choi J, Bae HB, Kim SJ, Chung ST, Jeong SW, Chung SS, Yoo KY, Jeong CY (2006) Antinociceptive effects and synergistic interaction with morphine of intrathecal metabotropic glutamate receptor 2/3 antagonist in the formalin test of rats. Neurosci Lett 394:222-226